4.5 Article

Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac)

Journal

MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 383, Issue 1-2, Pages 193-202

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2013.12.006

Keywords

cAMP; cAMP-dependent protein kinase A (MA); Exchange proteins directly activated by; CAMP (Epac)

Funding

  1. AIRC (Associazione Italiana Ricerca Cancro - Milan)
  2. Ricerca Corrente Funds of Fondazione IRCCS Ca' Granda-Milan [MFAG-8972]

Ask authors/readers for more resources

In the pituitary the activation of cyclic adenosine 3'-5'-monophosphate (cAMP) dependent pathways generates proliferative signals in somatotrophs, whereas in pituitary cells of other lineages its effect remains uncertain. Moreover, the specific role of the two main cAMP effectors, protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac), has not been defined. Aim of this study was to investigate the effect of cAMP on pituitary adenomatous cells proliferation and to identify PICA and Epac differential involvement. We found that cAMP increased DNA synthesis and cyclin D1 expression in somatotropinomas, whereas it reduced both parameters in prolactinomas and nonfunctioning adenomas, these effects being replicated in corresponding cell lines. Moreover, the divergent cAIVIP effects were mimicked by Epac and PICA analogs, which activated Rapl and CREB, respectively. In conclusion, we demonstrated that cAMP exerted opposite effects on different pituitary cell types proliferation, these effects being mediated by both Epac and PICA. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available